Panayotis Fasseas, MD, FACC

Publications

• Intravascular Lithotripsy (IVL) Assisted Percutaneous Balloon Mitral Valvuloplasty (PBMV): Refining the Technique

  (Chaddha A, Mason PJ, Fasseas P, Pearson PJ, Tyagi S, Plambeck C, Garster NC, Dang G, Salinger MH.) Structural Heart. 2021;5(3):332-337 SCOPUS ID: 2-s2.0-85103212431 01/01/2021

• Angiographic success and procedural complications in patients undergoing retrograde percutaneous coronary chronic total occlusion interventions: a weighted meta-analysis of 3,482 patients from 26 studies.

  (El Sabbagh A, Patel VG, Jeroudi OM, Michael TT, Alomar ME, Mogabgab O, Fuh E, Roesle M, Rangan BV, Abdullah S, Hastings JL, Grodin J, Kumbhani DJ, Alexopoulos D, Fasseas P, Banerjee S, Brilakis ES.) Int J Cardiol. 2014 Jun 15;174(2):243-8 PMID: 24768461 SCOPUS ID: 2-s2.0-84901241057 04/29/2014

• Prevalence and outcomes of intermediate saphenous vein graft lesions: findings from the stenting of saphenous vein grafts randomized-controlled trial.

  (Abdel-Karim AR, Da Silva M, Lichtenwalter C, de Lemos JA, Obel O, Addo T, Roesle M, Haagen D, Rangan BV, Makke L, Jeroudi OM, Raghunathan D, Saeed B, Bissett JK, Sachdeva R, Voudris VV, Karyofillis P, Kar B, Rossen J, Fasseas P, Berger P, Banerjee S, Brilakis ES.) Int J Cardiol. 2013 Oct 03;168(3):2468-73 PMID: 23561918 SCOPUS ID: 2-s2.0-84885653004 04/09/2013

• Paclitaxel-eluting stents reduce neointimal hyperplasia compared to bare metal stents in saphenous vein grafts: intravascular ultrasonography analysis of the SOS (Stenting of Saphenous Vein Grafts) trial.

  (Jeroudi OM, Abdel-Karim AR, Michael TT, Lichtenwalter C, de Lemos JA, Obel O, Addo T, Roesle M, Haagen D, Rangan BV, Raghunathan D, DaSilva M, Saeed B, Bissett JK, Sachdeva R, Voudris VV, Karyofillis P, Kar B, Rossen J, Fasseas P, Berger P, Banerjee S, Brilakis ES.) EuroIntervention. 2011 Dec;7(8):948-54 PMID: 22157480 SCOPUS ID: 2-s2.0-84855395954 12/14/2011

• Recurrent cardiovascular events with paclitaxel-eluting versus bare-metal stents in saphenous vein graft lesions: insights from the SOS (Stenting of Saphenous Vein Grafts) trial.

  (Michael TT, Abdel-karim AR, Papayannis A, Lichtenwalter C, de Lemos JA, Obel O, Addo T, Roesle M, Haagen D, Rangan BV, Saeed B, Bissett JK, Sachdeva R, Voudris VV, Karyofillis P, Kar B, Rossen J, Fasseas P, Berger PB, Banerjee S, Brilakis ES.) J Invasive Cardiol. 2011 Jun;23(6):216-9 PMID: 21646644 SCOPUS ID: 2-s2.0-79958118229 06/08/2011

• Continued benefit from paclitaxel-eluting compared with bare-metal stent implantation in saphenous vein graft lesions during long-term follow-up of the SOS (Stenting of Saphenous Vein Grafts) trial.

  (Brilakis ES, Lichtenwalter C, Abdel-karim AR, de Lemos JA, Obel O, Addo T, Roesle M, Haagen D, Rangan BV, Saeed B, Bissett JK, Sachdeva R, Voudris VV, Karyofillis P, Kar B, Rossen J, Fasseas P, Berger P, Banerjee S.) JACC Cardiovasc Interv. 2011 Feb;4(2):176-82 PMID: 21349456 SCOPUS ID: 2-s2.0-79951999985 02/26/2011

• Contemporary use of embolic protection devices in saphenous vein graft interventions: Insights from the stenting of saphenous vein grafts trial.

  (Badhey N, Lichtenwalter C, de Lemos JA, Roesle M, Obel O, Addo TA, Haagen D, Abdel-Karim AR, Saeed B, Bissett JK, Sachdeva R, Voudris VV, Karyofillis P, Kar B, Rossen J, Fasseas P, Berger PB, Banerjee S, Brilakis ES.) Catheter Cardiovasc Interv. 2010 Aug 01;76(2):263-9 PMID: 20665875 SCOPUS ID: 2-s2.0-77955146101 07/29/2010

• Reply.

  (Brilakis ES et al..) J Am Coll Cardiol. 2009 Dec 8;54(24):2338-9 PMID: 19958976 12/05/2009

• Clinical presentation and angiographic characteristics of saphenous vein graft failure after stenting: insights from the SOS (stenting of saphenous vein grafts) trial.

  (Lichtenwalter C, de Lemos JA, Roesle M, Obel O, Holper EM, Haagen D, Saeed B, Iturbe JM, Shunk K, Bissett JK, Sachdeva R, Voudris VV, Karyofillis P, Kar B, Rossen J, Fasseas P, Berger P, Banerjee S, Brilakis ES.) JACC Cardiovasc Interv. 2009 Sep;2(9):855-60 PMID: 19778774 SCOPUS ID: 2-s2.0-70349224293 09/26/2009

• A randomized controlled trial of a paclitaxel-eluting stent versus a similar bare-metal stent in saphenous vein graft lesions the SOS (Stenting of Saphenous Vein Grafts) trial.

  (Brilakis ES, Lichtenwalter C, de Lemos JA, Roesle M, Obel O, Haagen D, Saeed B, Gadiparthi C, Bissett JK, Sachdeva R, Voudris VV, Karyofillis P, Kar B, Rossen J, Fasseas P, Berger P, Banerjee S.) J Am Coll Cardiol. 2009 Mar 17;53(11):919-28 PMID: 19281920 SCOPUS ID: 2-s2.0-61549089702 03/14/2009

• Reply

  (Brilakis ES, Lichtenwalter C, de Lemos JA, Roesle M, Obel O, Haagen D, Saeed B, Gadiparthi C, Bissett JK, Sachdeva R, Voudris VV, Karyofillis P, Kar B, Rossen J, Fasseas P, Berger P, Banerjee S.) Journal of the American College of Cardiology. 8 December 2009;54(24):2338-2339 SCOPUS ID: 2-s2.0-70549083701 12/08/2009

• Carotid artery stenting will replace carotid endarterectomy.

  (McCormick DJ, Vlad T, Fasseas P.) Perspect Vasc Surg Endovasc Ther. 2007 Sep;19(3):223-7 PMID: 17911543 SCOPUS ID: 2-s2.0-38449115206 10/04/2007